Table 3.
Regression analysis of factors associated with severe leptospirosis.
| Parameters | Odds ratio (95% CI) unadjusted | p-value | Odds ratio (95% CI) Adjusteda | p-value |
|---|---|---|---|---|
| Gender | 1.02 (0.48–2.16) | 0.967 | 1.00 (0.99–1.02) | 0.807 |
| Age | 1.00 (0.99–1.02) | 0.731 | 0.96 (0.44–2.11) | 0.925 |
| Days of fever until enrollment | 1.05 (0.92–1.21) | 0.456 | 1.05 (0.92–1.21) | 0.465 |
| Leptospiremia (log10 copies/ml) | 1.66 (1.21–2.27) | 0.002* | 1.70 (1.23–2.34) | 0.001* |
| MAT titer (log scale) | 0.49 (0.03–8.11) | 0.617 | 0.35 (0.01–8.79) | 0.523 |
| Plasma NGAL (log10 ng/ml) | 8.51 (3.88–18.67) | < 0.001* | 9.46 (4.20–21.33) | < 0.001* |
| IL-6 (log10 pg/ml) | 2.61 (1.84–3.70) | < 0.001* | 2.82 (1.96–4.07) | < 0.001* |
pNGAL plasma neutrophil gelatinase-associated lipocalin, IL-6 interleukin 6, MAT microscopic agglutination test.
*p-value < 0.05.
aAdjusted for gender, age, and days of fever until enrollment.